Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
10.99
+0.05 (0.50%)
Jun 17, 2025, 12:00 PM - Market open
Orthofix Medical Stock Forecast
Stock Price Forecast
The 4 analysts that cover Orthofix Medical stock have a consensus rating of "Strong Buy" and an average price target of $23.33, which forecasts a 112.38% increase in the stock price over the next year. The lowest target is $22 and the highest is $24.
Price Target: $23.33 (+112.38%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 26, 2025.
Analyst Ratings
The average analyst rating for Orthofix Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 6, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +118.48% | Feb 26, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +100.27% | Feb 26, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +118.48% | Jan 22, 2025 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $20 → $22 | Strong Buy | Reiterates | $20 → $22 | +100.27% | Nov 8, 2024 |
Financial Forecast
Revenue This Year
831.57M
from 799.49M
Increased by 4.01%
Revenue Next Year
882.09M
from 831.57M
Increased by 6.08%
EPS This Year
0.17
from -3.30
EPS Next Year
0.85
from 0.17
Increased by 403.03%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 864.7M | 941.4M | 1.0B |
| Avg | 831.6M | 882.1M | 950.9M |
| Low | 792.8M | 826.4M | 883.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 8.2% | 13.2% | 14.3% |
| Avg | 4.0% | 6.1% | 7.8% |
| Low | -0.8% | -0.6% | 0.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.65 | 1.32 | 0.85 |
| Avg | 0.17 | 0.85 | 0.80 |
| Low | -0.28 | 0.39 | 0.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 686.1% | 0.5% |
| Avg | - | 403.0% | -6.0% |
| Low | - | 132.9% | -13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.